Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported):  April 22, 2021 Johnson & Johnson  (Exact name of registrant as specified in its charter)    New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  ☐             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17                CFR 240.14d-2(b))  ☐             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17                CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 0.250% Notes Due January 2022 JNJ22 New York Stock Exchange 0.650% Notes Due May 2024 JNJ24C New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange     Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐   Item 5.07 Submission of Matters to a Vote of Security Holders. (a)    T he 2021 Annual Meeting of Shareholders was held on April 22, 2021. (b)    At the 2021 Annual Meeting of Shareholders, the shareholders: • elected all 14 Director nominees named in the 2021 Proxy Statement to the Company's Board of Directors; • approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the “Compensation Discussion and Analysis” section of the 2021 proxy statement and the compensation of the Company's executive officers named in the 2021 Proxy Statement, as disclosed therein; • ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2021; • did not approve the shareholder proposal for a report on government financial support and access to COVID-19 vaccines and therapeutics; • did not approve the shareholder proposal for an independent board chair; • did not approve the shareholder proposal for a civil rights audit; and • did not approve the shareholder proposal for executive compensation bonus deferral. The following are the final voting results for each of the seven items voted on at the meeting. 1.      Election of Directors: Shares For Shares Against Shares Abstain Non-Votes M. C. Beckerle 1,810,423,629  16,477,577  4,324,787  361,631,706  D. S. Davis 1,760,086,673  65,980,033  5,159,287  361,631,706  I. E. L. Davis 1,788,731,967  37,515,980  4,978,046  361,631,706  J. A. Doudna 1,814,385,723  12,552,555  4,287,715  361,631,706  A. Gorsky 1,699,594,759  119,253,059  12,378,175  361,631,706  M. A. Hewson 1,777,336,871  49,480,838  4,408,284  361,631,706  H. Joly 1,775,886,493  50,205,313  5,134,187  361,631,706  M. B. McClellan 1,808,590,798  17,138,760  5,496,435  361,631,706  A. M. Mulcahy 1,614,611,649  195,380,452  21,233,892  361,631,706  C. Prince 1,649,989,314  176,521,719  4,714,960  361,631,706  A. E. Washington 1,773,129,639  53,253,564  4,842,790  361,631,706  M. A. Weinberger 1,809,184,712  16,475,730  5,565,551  361,631,706  N. Y. West 1,817,859,141  8,942,629  4,424,223  361,631,706  R. A. Williams 1,749,060,576  77,138,736  5,026,681  361,631,706  2.      Advisory Vote to Approve Named Executive Officer Compensation: For 986,844,148  Against 753,486,152  Abstain 90,895,693  Non-Votes 361,631,706  3.    Ratification of Appointment of PricewaterhouseCoopers LLC as the Independent Registered Public Accounting Firm for 2021 : For 2,080,036,325  Against 108,538,970  Abstain 4,282,404  Non-Votes N/A 4.      Shareholder Proposal - Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics: For 573,465,487  Against 1,231,071,897  Abstain 26,688,609  Non-Votes 361,631,706  5.      Shareholder Proposal - Independent Board Chair: For 789,938,907  Against 1,032,409,877  Abstain 8,877,209  Non-Votes 361,631,706  6.      Shareholder Proposal - Civil Rights Audit: For 611,417,042  Against 1,192,232,580  Abstain 27,576,371  Non-Votes 361,631,706  7.    Shareholder Proposal - Executive Compensation Bonus Deferral For 410,065,480  Against 1,406,949,986  Abstain 14,210,527  Non-Votes 361,631,706  SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     Johnson & Johnson        (Registrant)         Date:  April 26, 2021 By: /s/ Matthew Orlando       Matthew Orlando Secretary